Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The primary objective is to determine whether in patients with CIPN pain, treatment with
Qutenza has the same effect as treatment with duloxetine 60 mg daily.
Phase:
N/A
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)